Along with weight loss, exercise, and nutrition, employers now target sleep improvements in employees; a Republican member of the FTC supports Medicare drug price negotiations; sepsis is likely responsible for 20% of deaths worldwide.
Employers are focusing on improvements in workers’ sleep as a way to reduce company medical costs and improve employee health, according to Kaiser Health News. This new area of focus comes after wellness issues like weight loss, exercise, and nutrition were targeted by employers in the past. One company included in the article, Southern Co, has screened around 4000 of its 30,000 employees for sleep apnea in the past 3 years and saw a $1.2-million reduction in medical costs in 2018. One in 4 large employers offer programs to assist workers in improving sleep, the article reports, but the long-term effects remain unknown.
Christine Wilson, the Republican commissioner of the Federal Trade Commission (FTC) appointed by President Trump, expressed her support for Medicare negotiations on drug prices, The Hill reports. Speaking at a health care conference in Washington, DC, Wilson broke ranks from her Republican colleagues, who have historically opposed the notion. “I think part of the problem is that the federal government has not been able to negotiate under certain parts of Medicare and Medicaid for pharmaceutical prices,” Wilson said. Democrats passed a bill in the House in December addressing the issue, but the President and Senate Republicans rejected it.
A recent study published in Lancet lists sepsis, sometimes called blood poisoning, as a major contributor to deaths around the world. The disease arises when a body overreacts to an infection, which can lead to multiple-organ failure, NPR reports. About 270,000 deaths occur as a result of the disease in the United States each year, but the global death rate has dropped by about half since 1990. The study analyzed more than 100 million death certificates between 1990 and 2007 and concluded that sepsis is twice as common as previously thought. In 2017, researchers determined 11 million people worldwide died from the disease out of 56 million deaths.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More